A new condom designed to kill the HIV virus would be available to buy within months, after key regulatory approval. The new condom called VivaGel is effective in deactivating 99.9 per cent of HIV, herpes and human papilloma virus cases
It is being produced by Australian bio-tech firm Starpharma in partnership with another firm called Ansell, which is responsible for around 70 per cent of Australia’s condom market. It is hoped the gel will help reduce the transmission of HIV and other STIs, while also reducing the risk of pregnancy.
Australian bio-tech firm Starpharma has developed the antiviral Viva Gel, the active ingredient designed to tackle sexually transmitted infections, in the condom’s lubricant.
The product has already received a receipt of Conformity of Assessment Certification by the Australian Therapeutic Goods Administration meaning in a couple of months, the first-of-a-kind condom would be available in the market.